Follow on Google News News By Tag Industry News Country(s) Industry News
Follow on Google News | Quotient Clinical showcases Enabled-First-in-Human® programs at ASCPT 2016By: Quotient Clinical As part of the event, Quotient Clinical will be hosting a seminar entitled Accelerating timelines from candidate selection to proof-of-concept with Enabled-FIH programs. This seminar will cover unique and innovative approaches to reaching proof-of-concept (POC), with presentations from Hazel Hunt, VP of Research at Corcept Therapeutics, and Alyson Connor, Executive Director of Exploratory Clinical Pharmacology at Quotient Clinical. The speakers will describe integrated and adaptive clinical protocols which combine healthy volunteer and POC investigations, with case studies to highlight the benefits of using real-time, adaptive GMP manufacturing to adjust drug dose and product composition in response to emerging clinical data. Alyson Connor commented: “Our Enabled-First- For further details, visit www.quotientclinical.com/ For further information, please contact: Alyson Connor Executive Director, Exploratory Clinical Pharmacology Quotient Clinical Tel: +44 (0)7825 219 292 Alyson.Connor@ Robin Bodicoat Marketing Director Quotient Clinical Tel: +44 (0)115 931 5102 robin.bodicoat@ End
Account Email Address Disclaimer Report Abuse
|
|